Direkt zum Inhalt
Merck

Identification of novel, potent and selective inhibitors of Polo-like kinase 1.

Bioorganic & medicinal chemistry letters (2011-12-17)
Shaoqing Chen, David Bartkovitz, Jianping Cai, Yi Chen, Zhi Chen, Xin-Jie Chu, Kang Le, Nam T Le, Kin-Chun Luk, Steve Mischke, Goli Naderi-Oboodi, John F Boylan, Tom Nevins, Weiguo Qing, Yingsi Chen, Peter M Wovkulich
ZUSAMMENFASSUNG

A series of pyrimidodiazepines was identified as potent Polo-like kinase 1 (PLK1) inhibitors. The synthesis and SAR are discussed. The lead compound 7 (RO3280) has potent inhibitory activity against PLK1, good selectivity against other kinases, and excellent in vitro cellular potency. It showed strong antitumor activity in xenograft mouse models.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
RO3280, ≥98% (HPLC)